Centene Corporation Stock News

After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but

Centene (CNC) completes the sale of Apixio to New Mountain Capital in a bid to dispose of non-core assets and grow its core Managed Care business.

Health insurance stocks fell after a UnitedHealth Group executive's comments at a healthcare conference. UnitedHealth Group is seeing increased volumes of elective procedures for seniors.

Centene (CNC) wins managed care contract to serve people in Oklahoma through the SoonerSelect and SoonerSelect Children's Specialty Plan programs.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Medical-HMO industry is witnessing growth in customer base and an active M&A strategy. However, high technology expenses and medical personnel shortage raise concerns.

Centene's (CNC) health benefit ratio is estimated at 87.1-87.7% for 2023, signaling better operating efficiency.

ST. LOUIS , May 12, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Bernstein 39th Annual Strategic Decisions Conference, to be held Wednesday, May 31-Frida

The need for health insurance is only growing, and Centene is one of the biggest providers. Centene's growing membership base helped fuel solid results in the first quarter.

Centene's (CNC) first-quarter 2023 results grapple with higher operating expenses, partly offset by an expanding customer base. Management presently expects adjusted EPS to be at least $6.40 in 2023.

Centene (CNC) came out with quarterly earnings of $2.11 per share, missing the Zacks Consensus Estimate of $2.23 per share. This compares to earnings of $1.83 per share a year ago.

Centene's (CNC) first-quarter results are likely to reflect growth in premiums and lower costs.

Investing in the stock market under the current economic uncertainties can be confusing and risky. However, looking for companies with a proven growth and stability track record is a prudent place to

Continued Medicaid expansion bodes well for Centene. Viatris' drug pipeline should deliver modest growth in the years ahead.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.